Labcorp SVP sells 666 shares under 10b5-1 plan

LABCORP HOLDINGS INC. senior vice president and chief accounting officer Peter J. Wilkinson reported an open-market sale of common stock.

Accepted by SEC EDGAR 02/23/2026 - 09:13 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. senior vice president and chief accounting officer Peter J. Wilkinson reported an open-market sale of common stock. On February 19, 2026, he sold 666 shares of Labcorp common stock at a price of $277.94 per share in a transaction coded as an open-market sale. After this sale, he directly owns 1,852.2194 shares of Labcorp common stock. The transaction was executed under a pre-established trading plan adopted in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

Insider Trade Summary

Net Seller: 666 shares

Net Sell 1 txn

Insider Wilkinson Peter J

Role SVP, Chief Accounting Officer

Sold 666 shs ($185K)

Type	Security	Shares	Price	Value
Sale	Common Stock	666	$277.94	$185K

Holdings After Transaction: Common Stock — 1,852.2194 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) report for Peter J. Wilkinson?

Labcorp reported that Peter J. Wilkinson, its SVP and Chief Accounting Officer, sold 666 shares of common stock. The sale occurred on February 19, 2026, as an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan.

How many Labcorp (LH) shares did the insider sell and at what price?

Peter J. Wilkinson sold 666 shares of Labcorp common stock at a price of $277.94 per share. The transaction was classified as an open-market sale and was disclosed on a Form 4 insider trading report.

How many Labcorp (LH) shares does the insider hold after this sale?

Following the February 19, 2026 sale, Peter J. Wilkinson directly holds 1,852.2194 Labcorp common shares. This post-transaction ownership reflects his remaining direct stake after disposing of 666 shares in the reported open-market transaction.

Was the Labcorp (LH) insider stock sale under a Rule 10b5-1 plan?

Yes. The Form 4 states the transaction was made pursuant to a trading plan established under Rule 10b5-1. Such plans pre-schedule trades, allowing insiders to systematically sell shares according to preset instructions and timing.

What role does Peter J. Wilkinson hold at Labcorp (LH)?

Peter J. Wilkinson is identified as an officer of Labcorp serving as Senior Vice President and Chief Accounting Officer. His Form 4 filing reflects personal transactions in Labcorp common stock that he holds in a direct ownership capacity.

What does transaction code "S" mean in the Labcorp (LH) Form 4?

In this Form 4, transaction code "S" designates a sale of common stock in an open-market or private transaction. For Labcorp, it indicates Peter J. Wilkinson executed a straightforward open-market sale of 666 shares on February 19, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkinson Peter J

(Last) (First) (Middle)

231 MAPLE AVENUE

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		S(1)		666	D	$277.94	1,852.2194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.